Related Experiment Video
Updated: Aug 26, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Toxicity of sulfasalazine in systemic juvenile chronic arthritis
R Hertzberger-ten Cate1, A Cats
1Juliana Childrens Hospital, s-Gravenhage, The Netherlands.
Abstract:
The use of sulfasalazine as a long acting anti-rheumatic drug in patients with systemic JCA was studied in an open trial. Severe toxic side-effects in three of the four patients entered required discontinuation of the trial. These adverse effects included high fevers and a generalised exanthem. The symptoms were considered to represent an allergic reaction, most likely to the sulfa component of sulfasalazine. After resolution of these episodes the joint disease was suppressed for several weeks in these three children.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Overview
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Allergic Reactions
Drug toxicity: Idiosyncratic Reactions
